In compliance with section 17(b) of the Securities Act, we are disclosing that G Medical Innovations Holdings, Ltd. (NASDAQ: GMVD) is a client of TraDigital Marketing Group, Inc. and GMVD has an agreement in place to compensate TraDigital Marketing Group, Inc. a monthly cash fee of ten thousand dollars, plus seventy-one thousand dollars for publicly disseminating information about G Medical Innovations Holdings, Ltd via website, email, and SMS, and a one-time stock fee of fifty thousand shares of common stock, restricted under Rule 144, for TraDigital Marketing Group, Inc., investor awareness and digital marketing services. The stock is eligible for sale on 01/15/2022. Although we are not obligated to sell our shares, for the purpose of this disclosure, we suggest that you assume we will begin to sell all of our shares once the restriction is lifted on 01/15/2022. 

Investor awareness and investor relations services and programs are designed to help small-cap companies communicate their investment characteristics. TraDigital Marketing Group, Inc., investor awareness and advisory services include multimedia marketing and other awareness services.